Hepatitis B virus vaccine

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HIV InfectionsHepatitis B

Phase 1

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

CompletedNCT00100633

National Institute of Allergy and Infectious Diseases (NIAID)Hepatitis B, HIV Infections

Start: 2004-12-31End: 2007-10-31Target: 30Updated: 2008-10-01

Phase 2

Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals

CompletedNCT00272493

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

End: 2008-09-30Updated: 2021-10-25